In the yeast Saccharomyces cerevisiae, uptake of iron is largely regulated by the transcription factor Aft1. cDNA microarrays were used to identify new iron and AFT1-regulated genes. Four homologous genes regulated as part of the AFT1-regulon (ARN1-4) were predicted to encode members of a subfamily of the major facilitator superfamily of transporters. These genes were predicted to encode proteins with 14 membrane spanning domains and were from 26 to 53% identical at the amino acid level. ARN3 is identical to SIT1, which is reported to encode a ferrioxamine B permease. Deletion of ARN3 did not prevent yeast from using ferrioxamine B as an iron source; however, deletion of ARN3 and FET3, a component of the high affinity ferrous iron transport system, did prevent uptake of ferrioxaminebound iron and growth on ferrioxamine as an iron source. The siderophore-mediated transport system and the high affinity ferrous iron transport system were localized to separate cellular compartments. Epitopetagged Arn3p was expressed in intracellular vesicles that co-sediment with the endosomal protein Pep12. In contrast, Fet3p was expressed on the plasma membrane and was digested by extracellular proteases. These data indicate that S. cerevisiae has two pathways for ferrrioxamine-mediated iron uptake, one occurring at the plasma membrane and the other occurring in an intracellular compartment.
Iron is an essential nutrient for virtually every organism, and it is required for many cellular processes. Although iron is the second most abundant metal in the earth's crust, it is not readily bioavailable, because iron is largely present as poorly soluble complexes of ferric hydroxide. Therefore, organisms from microbes to man have developed mechanisms for obtaining iron from the environment. The budding yeast Saccharomyces cerevisiae has two characterized systems of elemental iron uptake, a low affinity system encoded by FET4 (1) and a high affinity system encoded by FET3 and FTR1 (2, 3) . Both transport systems require the action of surface reductases (FRE1 and FRE2) to reduce Fe(III) to the more soluble Fe(II) (4, 5) .
Reduction followed by transport of elemental iron is only one of the strategies that organisms use to accumulate iron. Most bacteria and fungi synthesize and secrete siderophores, low molecular weight compounds that specifically bind ferric iron. Siderophores bind ferric iron with high affinity, and the siderophore-iron complex can be captured by specific cellular transport systems. Most bacteria and fungi synthesize at least one type of siderophore but may express transporters specific to that siderophore as well as to siderophores secreted by other species (6) . Prokaryotic mechanisms of siderophore uptake are well described (7) , but much less is known about eukaryotic siderophore utilization (8) . Although neither budding nor fission yeast secrete siderophores, they are capable of taking up siderophore-bound iron (9, 10) .
The high affinity transport system for elemental iron in S. cerevisiae is under the control of the iron-dependent transcriptional regulator, Aft1p (11, 12) . Through the use of cDNA microarrays representing virtually the entire genome of S. cerevisiae, we have identified genes that are regulated according to iron availability and Aft1p expression. Here, we report that four homologous members of the major facilitator superfamily of transporters are transcriptionally regulated by Aft1p. One of these, ARN3, is identical to SIT1, a gene reported to have a role in ferrioxamine B-mediated iron transport (13) . Ferrioxamine B is a hydroxamate-type siderophore that is synthesized and secreted in its iron-free form, desferrioxamine B (DFO), 1 by several species of actinomycetes (14) . Here we demonstrate that both ARN3 and FET3 can facilitate the uptake of DFO-bound iron (DFO-Fe). We further demonstrate that although Fet3p is localized to the cell surface, Arn3p is found predominantly in intracellular, post-Golgi vesicles.
MATERIALS AND METHODS
Yeast Strains, Plasmids, and Media-Strain DBY7286 (MATa ura3 GAL) and congenic aft1 mutants were used for cDNA microarray analysis and were constructed as described (15) . All other strains were constructed in YPH499 MATa ura3-52 lys2-801(amber) ade2-101(ochre) trp1-⌬63 his3-⌬200 leu2-⌬1 (Yeast Genetic Stock Center, Berkeley, CA). PCR-mediated gene disruption was used to generate deletions of the ARN genes (16) . The following primers were used to amplify the HISG-URA3-HISG cassette from the plasmid pMPY-ZAP: for ARN1, 5Ј-GGGAATGGAACACGAGTTGAATCCTGAGACTCATAACGATTCC-AACTCCGACTCCTCACTATAGGGCGAATTGG-3Ј and 5Ј-CGTGTCG-ACATATTCGCCATCCTCGATGTATTCCACAGCAACAGTATCAGTC-CTAAAGGGAACAAAAGCT-3Ј; for ARN2, 5Ј-GTAATGAACTGATGGT-TGATGAAAAGAGGATGACGATTCGTCGCCCAGAGATGCTCACTA-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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¶ ¶ To whom correspondence should be addressed. E-mail: carolinep@intra.niddk.nih.gov. TAGGGCGAATTGG-3Ј and 5Ј-CCAGTCATTGATAGGATCATCTTCC-TTGGTTTGGACATATTCTCTGTCAGGTAACCTAAAGGGAACAAAA-GCTGG-3Ј; for ARN3, 5Ј-GACCCTGGTATTGCTAATCATACCCTCCC-CGAGGAATTTGAAGAGGTTGTCCTCACTATAGGGCGAATTGG-3Ј  and 5Ј-CCAAACCTATGATACATAAAATCTTTTGAACATAGCGGTAA-GACATGACTAAAGCCTAAAGGGAACAAAAGCT-3Ј; and for ARN4,  5Ј-TGACAATTTAGACGATAAAAGCACTGTCTGCTACAGCGAAAAG-ACAGATAGCCTCACTATAGGGCGAATTGG-3Ј and 5Ј-TATCCAATT-ACACGACGGAGCCATGATTGTTGTTTGATTTTGAGCTTCTCTTCT-AAAGGGAACAAAAGCT-3Ј . Deletions were confirmed by PCR and 5-fluoroorotic acid-resistant clones were selected. Construction of double, triple, and quadruple ARN deletion mutants was performed by repeated PCR-based gene disruption and by mating and sporulating single deletion strains. Deletion of FET3 was performed as described (3) . The strain YPH499 FET3-HA FTR1-myc, which constitutively overexpresses integrated copies of HA-tagged FET3 and myc-tagged FTR1 under the control of the phosphoglycerate kinase promoter, was constructed as described (17) . The ARN3-HA strain, which expresses a triple copy of the HA epitope fused to the carboxyl terminus of Arn3p, was constructed by PCR epitope tagging as described using the plasmid pMPY-3xHA (18) and the following primers: 5Ј-TTGAAAAATAAATT-CTTTACGCACTTTACAAGCAGTAAAGATAGGAAAGATGAACAAAA-GCTGGAGCTCCAC-3Ј and 5Ј-ACTATGTAGTAGCTATATGTGCATG-TATGAAATTATTTGGGTGAGATAATACTATAGGGCGAATTGGGTA-CC-3Ј. Integration of the HA epitope was confirmed by PCR and by Western blotting. The plasmid pARN3-HA was constructed by extracting genomic DNA from the ARN3-HA strain and digesting it with NruI and PstI. After electrophoresis, DNA fragments from 3.0 to 5.0 kb were extracted (GELase, Epicentre Technologies), ligated into PstI-and SmaI-digested pRS415 (Stratagene), and used to transform Escherichia coli DH5-␣. Clones were screened by colony hybridization using a 0.46-kb EcoRV fragment of ARN3, and positive clones were further analyzed by restriction mapping. Plasmid-encoded expression of Arn3p-HA was confirmed by Western blotting. Rich medium (YPD) and defined medium (SD) were prepared as described (19) . Defined iron media were prepared as described (15) .
Microarrays-Strains were cultured in the exponential phase of growth for more than five generations in either SD complete medium or defined iron media with 20 M (low iron), 100 M (optimal iron), or 500 M (high iron) added ferrous ammonium sulfate. Low iron and high iron culture conditions were selected in which the rate was of growth was moderately but not severely (Ͻ 2-fold difference when compared with the optimal iron condition) affected by iron limitation or excess (data not shown). Cultures were harvested at a uniform cell density of 1 ϫ 10 7 cells/ml. Total RNA was extracted using Trizol (Life Technologies, Inc.) according to the manufacturer's instructions. Probe preparation, microarray production, hybridization, and data analysis were performed as described (20, 21) .
Northern Analysis-Yeast were grown to mid-log phase in SD medium or defined iron media containing the indicated amount of ferrous iron. Total RNA was extracted using Trizol (Life Technologies, Inc.), and Northern blot analysis was performed as described (11) . Probes for the ARN genes were as follows: for ARN1, a 1.15-kb HincII fragment; for ARN2, a 0.8-kb NdeI fragment; for ARN3, a 0.46-kb EcoRV fragment; and for ARN4, a 0.7-kb AlwNI fragment. Restriction fragments were isolated from a PCR-amplified product corresponding to the open reading frame of each ARN gene.
Desferrrioxamine B Plate Assay and Iron Uptake Assay-For the plate assay, modified synthetic complete media were used in which copper and iron were omitted and 1 M copper sulfate and 100 M bathophenanthroline sulfonate (BPS, a ferrous iron chelator that is not taken up by yeast) were added. Trace amounts of iron are supplied by agar (Difco). Desferrioxamine Bϩ plates also included 100 M of the mesylate derivative of DFO (Desferal, Sigma). Yeast strains were grown for 24 h on plates of defined-iron media (approximately 10 M iron) to deplete intracellular iron stores. Cells were then suspended in water at 2 ϫ 10 6 cells/ml, plated in serial 10-fold dilutions, and incubated at 30°C for 3 days prior to imaging. Ferrous iron uptake assays were performed as described using 1 M 55 Fe, except that washes were omitted and cells were spun through a column of 10% bovine serum albumin before scintillation counting (22) . For DFO uptake assays, 1 M ferric 55 Fe and 1 M DFO were used. Immunofluorescence, External Protease Digestion, and Western Blotting-Strains were grown to mid-log phase in defined iron media containing 10 M ferrous ammonium sulfate to induce the expression of Arn3. Cells were washed and prepared for immunofluorescence microscopy as described (3). Primary antibody was affinity purified HA.11 (BAbCo) at 1:500, and secondary antibody was Cy3-conjugated polyclonal anti-mouse IgG from donkey (Jackson Immunoresearch) at 1:500. Cells were imaged on a Nikon photomicroscope equipped with 100ϫ/1.3NA objective with Nomarski optics. Images were acquired using IP Labs software and a CCD camera (Princeton Instruments). Susceptibility to external protease in living cells was performed essentially as described (23) . Washed cells were resuspended at 2 ϫ 10 7 cells/ml and incubated for 1 h with 2 mg/ml proteinase K or for 20 min with 0.7 mg/ml Pronase prior to lysis. Cells were lysed on ice in 1.85 M NaOH and 1% 2-mercaptoethanol for 10 min followed by precipitation on ice in 25% trichloroacetic acid for 30 min. Precipitates were resuspended in SDS sample buffer containing 0.1 M Tris base before SDSpolyacrylamide gel electrophoresis. Western blotting was performed using a 1:2000 dilution of HA.11 ascites (BAbCo). The secondary antibody consisted of anti-mouse IgG conjugated to horseradish peroxidase (Amersham Pharmacia Biotech) diluted 1:3000 and was detected by chemiluminescence (Pierce), according to the manufacturer's protocols.
Membrane Fractionation and Western Blotting-Cell cultures were grown to an A 600 of 1.0 in iron limiting conditions (CM ϩ BPS 40 M). Briefly, cells were washed, spheroplasted, and processed as described previously (24) . Membranes were applied to an 0 -25% Iodixanol (Life Technologies) gradient, which was centrifuged at 10,000 ϫ g for 2 h and then fractionated. Samples from each fraction were loaded on a 12% SDS-polyacrylamide gel electrophoresis, which was transferred to a nitrocellulose membrane. The localization of fractions containing mitochondria, vacuoles, endoplasmic reticulum, and late endosomes was determined by Western analysis using antibodies against mitochondrial porin (Molecular Probes), carboxypeptidase Y (Molecular Probes), dolichol phosphate mannose synthetase (Molecular Probes), and Pep12 (a gift of Dr. Scott Emr, UCSD), respectively. The refractive index of each fraction was determined by a Bausch and Lomb refractometer.
RESULTS
Identification and Sequence Analysis of ARN Genes-cDNA microarray analysis was performed to examine the yeast genome for new genes involved in iron metabolism (20, 21) . This technique allows each gene in the yeast genome to be analyzed for differences in mRNA transcript levels when a pair of strains or culture conditions is compared. We compared mRNA obtained from yeast expressing a constitutively active allele of AFT1, AFT1-1 up , and a congenic strain with the AFT1 gene deleted, aft1⌬. Expression of AFT1-1 up results in high levels of transcription of the genes of high affinity iron uptake, and a failure of these genes to be repressed by exogenous iron (11) . Conversely, in aft1⌬ strains, transcription of genes involved in high affinity iron uptake is greatly reduced, even under conditions of iron depletion. Genes were identified in microarrays that were more highly expressed in an AFT1-1 up strain than in the aft1⌬ strain. Similar comparisons were made between AFT1-1 up and wild type strains and between wild type strains grown in reduced amounts of iron or increased amounts of iron (Fig. 1A) . Four of the genes identified in this fashion, YHL040C, YHL047C, YEL065W, and YOL158C, were chosen for further study. These genes are predicted to encode highly homologous members of a subfamily of the major facilitator superfamily of transporters (25) (26) (27) . Two other members of this subfamily, YKR106W and YCL073C, were not differentially expressed in the arrays. The DNA regions upstream of the open reading frames of YHL040C, YHL047C, YEL065W, and YOL158C were analyzed, and all were found to contain AFT1 consensus binding sites (12) within 500 nucleotides of the start codon, as would be expected for AFT1-regulated genes (Fig.  1B) . These genes were designated ARN1, 2, 3, and 4, respectively.
A comparison of the predicted amino acid sequences of these genes (Fig. 1C) revealed that the overall sequence identity ranges from 26 to 53%, with ARN1 and ARN2 showing the greatest sequence identity and ARN4 the least. The predicted proteins have 14 membrane-spanning domains, and both the amino and carboxyl termini are predicted to be cytosolic.
Regulation of ARN Expression by Iron and AFT1-To confirm the results of the cDNA microarrays, iron-and AFT1-de-pendent regulation of the mRNA levels of ARN1-4 were examined by Northern blot analysis (Fig. 2) . The transcript profile for all four ARN genes was found to be similar. In the wild type strain, ARN transcript levels were high when cells were grown in iron-limited media and greatly reduced when higher concentrations of iron were present (lanes 1-7) . The effects of expression of different AFT1 alleles on ARN transcript levels was examined in cells grown in iron replete media (lanes 8 -10) . In these media, AFT1-dependent transcription is low, as are high affinity iron uptake and surface reductase activities (data not shown). ARN transcript levels were low in both AFT1 and aft1⌬ strains (lanes 8 and 9) . In contrast, ARN transcripts were abundant in an AFT1-1 up strain (lane 10). These results suggest that transcription of ARN1-4 is a direct consequence of AFT1 activation and is not a secondary result of iron deprivation.
The Role of ARN3 and FET3 in Desferrioxamine-mediated Growth and Iron Uptake-ARN3 was reported to be involved in the transport of the hydroxamate siderophore DFO-Fe (13) . To determine the genetic requirements for growth with DFO-Fe as an iron source, we examined the capacity of DFO-Fe to supply iron to yeast strains with deletions in ARN genes (Fig. 3) . Both ARN ϩ and arn⌬ strains showed decreased growth on ironlimited media. A deletion in the high affinity iron transport system (fet3⌬; Fig. 3B ) resulted in no detectable growth in iron-limited medium. Both ARNϩ and arn-deleted strains grew well in iron-limited medium when DFO-Fe was added as an iron source (Fig. 3C) . Strains with a functional high affinity iron transport system also were able to grow in DFO-Fe medium when the ARN genes were deleted in combination (pairs, triplets, or quadruplicate; data not shown). Deletion of FET3 had no effect on growth in DFO-Fe media in an ARN ϩ strain or when ARN1, 2, or 4 was deleted (Fig. 3D) . Deletion of ARN3 in a fet3⌬ strain, however, completely prevented growth on DFO- Fe. Expression of ARN3 by either a high or low copy number plasmid completely restored growth on DFO-Fe medium, whereas expression of ARN1 from a high copy number plasmid did not complement the growth deficit (data not shown). These data suggest the existence of two independent systems for the transport of iron bound to DFO: one system that requires the high affinity iron transporter composed of FET3 and FTR1 and a second system that requires ARN3.
We measured the cellular uptake of iron as Fe(II) and as DFO-Fe(III) in ARN deletion strains (Fig. 4) . Deletion of individual ARN genes had no effect on the rate of Fe(II) uptake in strains expressing FET3 (Fig. 4A) . In contrast, the rate of uptake of iron from DFO-Fe was similar in wild type cells and ⌬fet3 cells but was reduced 4-fold in arn3⌬ cells and was virtually undetectable in an arn3⌬ fet3⌬ strain (Fig. 4B) . Again, these data indicate that uptake of DFO-bound iron is dependent on either FET3 or ARN3.
Localization of ARN3 to Intracellular Vesicles-Transport of iron through the high affinity system occurs at the plasma membrane. Both components of the high affinity iron transport system, the permease (Ftr1p) and oxidase (Fet3p), have been localized to the plasma membrane by immunological methods (3, 28, 29) . We performed indirect immunofluorescence to determine whether DFO-mediated iron transport occurs at the plasma membrane. Strains were constructed in which the chromosomal copy of ARN3 carried a triple-copy of the HA epitope at the carboxyl terminus or which contained an integrated copy of an overexpression cassette of HA-tagged FET3 and Myc epitope-tagged FTR1 (Fig. 5) . We confirmed that the epitopetagged version of ARN3 was functional by cloning the HAtagged allele into a low copy number plasmid and observing complementation of both the growth defect on DFO and the uptake defect of DFO-Fe iron of an ⌬arn3 ⌬fet3 strain (data not shown). When the strains were grown in media containing limiting amounts of iron to induce ARN3 expression, HAtagged Arn3p was not detected on the plasma membrane but rather in multiple, small, intracellular vesicles that tended to cluster at the periphery of the cell (Fig. 5, A-E) . In contrast, HA-tagged Fet3p was detected predominantly on the plasma membrane, although some intracellular signal was detected as well (Fig. 5, G-I) .
The cellular localization of Arn3p may have been altered by fixation and antibody binding procedures. Unfortunately, when green fluorescent protein was fused to either the amino-or carboxyl terminus of ARN3, the cleaved green fluorescent protein moiety appeared in the lumen of the vacuole, thus precluding the visualization of Arn3p in living cells (data not shown). To determine whether Arn3p was expressed on the plasma membrane, we treated intact cells with extracellular proteases and analyzed lysates by Western blotting (Fig. 6) . As expected, Fet3p-HA was sensitive to extracellular proteases and was detected as an approximately 16-kDa fragment after protease digestion (lanes 9 and 10) . In contrast, Arn3p-HA was highly resistant to extracellular protease (lanes 5 and 6) but was completely degraded by protease in the presence of detergent (lane 8). The susceptibility of Arn3p-HA to external protease was not altered when cells were grown in the presence of DFO, suggesting that Arn3p is not recruited to the plasma membrane in the presence of its transport substrate. These data confirm that the majority of Fet3p is localized to the plasma membrane in living cells and suggests that the majority of Arn3p is sequestered in an intracellular compartment.
To characterize the Arn3p-containing intracellular vesicles, we fractionated Arn3p-HA-expressing cells and separated subcellular organelles by density gradient centrifugation. Western blot analysis demonstrated that Arn3p-HA was not associated with vacuoles (Cpy1), endoplasmic reticulum (Dpm1), or mitochondria (Fig. 7, Porin) . The distribution of Arn3p, however, was coincident with that of Pep12p, a protein enriched in late endosomes/prevacuoles (30) . These results confirm the immunofluorescence studies and indicate that Arn3p is localized primarily in intracellular vesicles. DISCUSSION We have used microarray technology to identify four highly homologous genes that are regulated by the iron-dependent transcription factor Aft1p. Although one of the genes, ARN3 (SIT1), was previously reported to exhibit an AFT1-independent pattern of iron regulation and not to contain an AFT1 consensus binding site (13), our results show that ARN3 is ironand AFT1-regulated. Transcriptional regulation by AFT1 was confirmed by Northern analysis, and inspection of upstream sequences indicate an Aft1p consensus binding site for each of the ARN genes (12, 31) . The ARN genes were grouped as members of the major facilitator superfamily of transporters on the basis of their predicted amino acid sequences (25) (26) (27) . Walker A and Walker B motifs are absent, indicating that these potential permeases are not ATP-binding cassette-type transporters and likely require proton symport to energize the transport of substrate. Members of this gene family have 12-14 membrane-spanning domains and function as uniporters, symporters, and antiporters of a variety of small molecules, including drugs, sugars, and amino acids. The ARN genes are predicted to have 14 transmembrane domains, a less common feature of the major facilitator superfamily transporters that is shared by the multidrug proton antiporter subfamily. Interestingly, these two subfamilies also transport the largest substrates of any of the major facilitator superfamily subfamilies, as siderophores are approximately 500 -1000 M r and the larger drugs 400 -500 M r .
Very little is known about siderophore uptake in eukaryotes, although the process has been studied in detail in prokaryotes (7) . In the E. coli K-12 strain, a single siderophore, enterobactin, is synthesized and secreted, whereas six different ironsiderophore uptake systems have been identified, each one specific for a different siderophore. The sequence and predicted structure of the ARN family of transporters, however, do not resemble those of prokaryotic siderophore transporters; presumably eukaryotes have evolved distinct mechanisms for siderophore-mediated iron uptake. The fungus Ustilago maydis exhibits two different pathways of siderophore-mediated iron uptake (32, 33) . The native siderophore ferrichrome enters the cell as an iron chelate and over time accumulates in vesicles in the iron-free form. Xenosiderophores, such as ferrioxamine B, as well as the native siderophore ferrichrome A, do not cross the plasma membrane but are bound at the cell suface where the iron is reduced extracellularly before entering the cell. The capacity of microbes to take up iron from siderophores that are secreted by other species appears to be well conserved and likely provides a selective advantage in a natural environment where many species compete for nutrients.
Our studies indicate that S. cerevisiae has two different systems of DFO-mediated iron transport: one that requires the FET3-dependent, high affinity, iron transport system and a second that requires ARN3. In the first system, DFO-Fe could act as a substrate for surface reductases, releasing Fe(II), which is then taken up by the high affinity iron transport system. This transport system is independent of the ARN genes. The second transport system for DFO-Fe only becomes apparent in the absence of Fet3p. This transport system is specific for ARN3; deletion of the other highly homologous ARN genes either singly or in combination does not lead to a defect in DFO-Fe transport.
Our finding that Arn3p (and other ARN family members; data not shown) is primarily localized to endosome-like vesicles indicates that ARN3-dependent uptake differs from FET3-dependent uptake. Arn3p was localized by immunofluorescence and biochemical techniques to intracellular vesicles. Although our data cannot exclude the possibility that a small amount of Arn3p localized to the cell surface, it clearly shows that the bulk of the protein is present in an intracellular organelle. This result suggests two possibilities: 1) that Arn3p localizes briefly to the cell surface, where it facilitates DFO-Fe tranport, before being internalized or 2) that DFO-Fe is delivered to Arn3p in an intracellular, metal-exchanging compartment. The entry of DFO-Fe could occur by fluid phase endocytosis, or alternatively, DFO-Fe chelates may be recognized by specific binding proteins at the plasma membrane, which are then internalized. In either case, the site of iron release may be the intracellular vesicle. A precedent for this system of intravesicular iron release occurs in mammalian transferrin-dependent iron uptake A membrane fraction from cells expressing Arn3p-HA was applied to a Iodixanol gradient. After centrifugation, the gradient was fractionated, and samples from each fraction analyzed by SDS gel electrophoresis followed by Western blotting. The blots were probed with antibodies to marker antigens: vacuole, carboxypeptidase Y (Cpy1); endoplasmic reticulum, dolichol phosphate mannose synthetase (Dpm1); mitochondria, porin (Porin); late endosome/prevacuole, Pep12p (Pep12). (34) . In this system, the "siderophore" is transferrin, which binds with high affinity to Fe(III) in the extracellular fluid. Diferric transferrin then binds to the transferrin receptor on the plasma membrane, and the complex is internalized via receptor-mediated endocytosis. Iron is released from transferrin within the endocytic vesicle and reduced, Fe(II) is transported across the endosomal membrane by the permease DMT1. If siderophore-iron uptake in budding yeast is similar to transferrin-iron uptake in mammalian cells, then a testable prediction is that an intracellular ferrireductase may exist. Studies that test this prediction are in progress.
